Does Dipeptidyl Peptidase IV (DPP-IV) Inhibition Help With Cognitive Protection?
In animal studies, the DPP-IV inhibitor alogliptin reduced diabetes-related brain inflammation and memory impairment.
Weak EvidenceEvidence Summary
In animal studies, the DPP-IV inhibitor alogliptin reduced diabetes-related brain inflammation and memory impairment.
Effective Dose
20–40 mg/kg/day in rats (no human dose established)
Supporting Studies
Every PMID below is a real paper indexed in PubMed. Click any to read the abstract or full text. These are the specific studies HypeCheck cited to support this claim — verify the chain yourself.
Products Containing Dipeptidyl Peptidase IV (DPP-IV) Inhibition
No products analyzed yet that contain this ingredient.